{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:03:51Z","timestamp":1786737831505,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Cancer"],"published-print":{"date-parts":[[2021]]},"DOI":"10.4103\/ijc.ijc_283_20","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T02:43:12Z","timestamp":1624243392000},"page":"469","source":"Crossref","is-referenced-by-count":2,"title":["Testing for latent tuberculosis before starting patients on immune checkpoint inhibitors"],"prefix":"10.4103","volume":"58","author":[{"given":"Chirag","family":"Dhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-509X.318898-1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bj.2019.09.002","article-title":"Immune checkpoint inhibitors win the 2018 Nobel Prize","author":"Huang","year":"2019","journal-title":"Biomed J","ISSN":"https:\/\/id.crossref.org\/issn\/2319-4170","issn-type":"print"},{"key":"key-10.4103\/0019-509X.318898-2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jiac.2018.06.016","article-title":"Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents","author":"Takata","year":"2019","journal-title":"J Infect Chemother"},{"key":"key-10.4103\/0019-509X.318898-3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cmi.2017.12.003","article-title":"Infectious complications associated with the use of immune checkpoint inhibitors in oncology: Reactivation of tuberculosis after anti PD-1 treatment","author":"Picchi","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"key-10.4103\/0019-509X.318898-4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/0284186X.2015.1125017","article-title":"Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma","author":"Lee","year":"2016","journal-title":"Acta Oncol"},{"key":"key-10.4103\/0019-509X.318898-5","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jtho.2016.07.006","article-title":"Anti-PD1 Antibody treatment and the development of acute pulmonary tuberculosis","author":"Fujita","year":"2016","journal-title":"J Thorac Oncol"},{"key":"key-10.4103\/0019-509X.318898-6","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jtho.2017.03.012","article-title":"Pericardial tamponade caused by a hypersensitivity response to tuberculosis reactivation after Anti-PD-1 treatment in a patient with advanced pulmonary adenocarcinoma","author":"Chu","year":"2017","journal-title":"J Thorac Oncol"},{"key":"key-10.4103\/0019-509X.318898-7","first-page":"659","article-title":"Tuberculosis infection in a patient treated with nivolumab for non-small cell lung cancer: Case report and literature review","author":"van","year":"2019","journal-title":"Front Oncol"},{"key":"key-10.4103\/0019-509X.318898-8","doi-asserted-by":"crossref","first-page":"eaat2702","DOI":"10.1126\/scitranslmed.aat2702","article-title":"Tuberculosis following PD-1 blockade for cancer immunotherapy","author":"Barber","year":"2019","journal-title":"Sci Transl Med"},{"key":"key-10.4103\/0019-509X.318898-9","doi-asserted-by":"crossref","first-page":"e1007289","DOI":"10.1371\/journal.ppat.1007289","article-title":"Circulating HLA-DR+CD4+effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis","author":"Ahmed","year":"2018","journal-title":"PLoS Pathog"},{"key":"key-10.4103\/0019-509X.318898-10","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection-United States, 2010","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.4103\/0019-509X.318898-11","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S1470-2045(19)30674-6","article-title":"Immune checkpoint inhibitors and tuberculosis: An old disease in a new context","author":"Langan","year":"2020","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0019-509X.318898-12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ebiom.2016.12.009","article-title":"Unbiased identification of blood-based biomarkers for pulmonary tuberculosis by modeling and mining molecular interaction networks","author":"Sambarey","year":"2017","journal-title":"EBioMedicine"},{"key":"key-10.4103\/0019-509X.318898-13","doi-asserted-by":"crossref","first-page":"11948","DOI":"10.1038\/s41598-017-10773-5","article-title":"Circulating mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10+ Th17 CD4 T-cells differentiate latent from active tuberculosis","author":"Rakshit","year":"2017","journal-title":"Sci Rep"},{"key":"key-10.4103\/0019-509X.318898-14","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","author":"Carmona","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:00:16Z","timestamp":1786734016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_283_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["318898"],"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_283_20","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}